link
Bookmarks
Ovarian Carcinoma Overview
Akram M. Shaaban, MBBCh
To access 4,300 diagnoses written by the world's leading experts in radiology, please log in or subscribe.Log inSubscribe
5

Overview

  • Classification

    Pathology

    • Routes Spread

      • General Features

        Imaging Findings

        • Detection

          • Staging

            • Restaging

              Clinical Issues

              • Presentation

                • Cancer History

                  • Treatment Options

                    Reporting Checklist

                    • T Staging

                      • N Staging

                        • M Staging

                          Selected References

                          1. Nik NN et al: Origin and pathogenesis of pelvic (ovarian, tubal, and primary peritoneal) serous carcinoma. Annu Rev Pathol. 9:27-45, 2014
                          2. American Cancer Society: Cancer Facts and Figures 2013. http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-036845.pdf. Accessed October 7, 2013
                          3. Espada M et al: Diffusion-weighted magnetic resonance imaging evaluation of intra-abdominal sites of implants to predict likelihood of suboptimal cytoreductive surgery in patients with ovarian carcinoma. Eur Radiol. 23(9):2636-42, 2013
                          4. Li J et al: Ovarian serous carcinoma: recent concepts on its origin and carcinogenesis. J Hematol Oncol. 5:8, 2012
                          5. Nougaret S et al: Ovarian carcinomatosis: how the radiologist can help plan the surgical approach. Radiographics. 32(6):1775-800; discussion 1800-3, 2012
                          6. Lalwani N et al: Histologic, molecular, and cytogenetic features of ovarian cancers: implications for diagnosis and treatment. Radiographics. 31(3):625-46, 2011
                          7. American Joint Committee on Cancer: AJCC Cancer Staging Manual. 7th ed. New York: Springer. 419-28, 2010
                          8. Low RN et al: Diffusion-weighted MRI of peritoneal tumors: comparison with conventional MRI and surgical and histopathologic findings--a feasibility study. AJR Am J Roentgenol. 193(2):461-70, 2009
                          9. Suga K et al: F-18 FDG PET-CT findings in a case of normal-sized ovarian cancer syndrome. Clin Nucl Med. 34(10):706-9, 2009
                          10. Booth SJ et al: The accurate staging of ovarian cancer using 3T magnetic resonance imaging--a realistic option. BJOG. 115(7):894-901, 2008
                          11. Ferreira CR et al: Mucinous ovarian tumors associated with pseudomyxoma peritonei of adenomucinosis type: immunohistochemical evidence that they are secondary tumors. Int J Gynecol Cancer. 18(1):59-65, 2008
                          12. Fujii S et al: Detection of peritoneal dissemination in gynecological malignancy: evaluation by diffusion-weighted MR imaging. Eur Radiol. 18(1):18-23, 2008
                          13. Sebastian S et al: PET-CT vs. CT alone in ovarian cancer recurrence. Abdom Imaging. 33(1):112-8, 2008
                          14. Thomassin-Naggara I et al: Dynamic contrast-enhanced magnetic resonance imaging: a useful tool for characterizing ovarian epithelial tumors. J Magn Reson Imaging. 28(1):111-20, 2008
                          15. Tsili AC et al: Adnexal masses: accuracy of detection and differentiation with multidetector computed tomography. Gynecol Oncol. 110(1):22-31, 2008
                          16. Kim CK et al: Detection of recurrent ovarian cancer at MRI: comparison with integrated PET/CT. J Comput Assist Tomogr. 31(6):868-75, 2007
                          17. Liu J et al: Ultrasonography, computed tomography and magnetic resonance imaging for diagnosis of ovarian carcinoma. Eur J Radiol. 62(3):328-34, 2007
                          18. Chen M et al: Differentiation between malignant and benign ovarian tumors by magnetic resonance imaging. Chin Med Sci J. 21(4):270-5, 2006
                          19. Woodward PJ et al: From the archives of the AFIP: radiologic staging of ovarian carcinoma with pathologic correlation. Radiographics. 24(1):225-46, 2004
                          20. Seidman JD et al: Pathology of ovarian carcinoma. Hematol Oncol Clin North Am. 17(4):909-25, vii, 2003
                          21. Coakley FV: Staging ovarian cancer: role of imaging. Radiol Clin North Am. 40(3):609-36, 2002
                          Related Anatomy
                          Loading...
                          Related Differential Diagnoses
                          Loading...
                          References
                          Tables

                          Tables

                          Overview

                          • Classification

                            Pathology

                            • Routes Spread

                              • General Features

                                Imaging Findings

                                • Detection

                                  • Staging

                                    • Restaging

                                      Clinical Issues

                                      • Presentation

                                        • Cancer History

                                          • Treatment Options

                                            Reporting Checklist

                                            • T Staging

                                              • N Staging

                                                • M Staging

                                                  Selected References

                                                  1. Nik NN et al: Origin and pathogenesis of pelvic (ovarian, tubal, and primary peritoneal) serous carcinoma. Annu Rev Pathol. 9:27-45, 2014
                                                  2. American Cancer Society: Cancer Facts and Figures 2013. http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-036845.pdf. Accessed October 7, 2013
                                                  3. Espada M et al: Diffusion-weighted magnetic resonance imaging evaluation of intra-abdominal sites of implants to predict likelihood of suboptimal cytoreductive surgery in patients with ovarian carcinoma. Eur Radiol. 23(9):2636-42, 2013
                                                  4. Li J et al: Ovarian serous carcinoma: recent concepts on its origin and carcinogenesis. J Hematol Oncol. 5:8, 2012
                                                  5. Nougaret S et al: Ovarian carcinomatosis: how the radiologist can help plan the surgical approach. Radiographics. 32(6):1775-800; discussion 1800-3, 2012
                                                  6. Lalwani N et al: Histologic, molecular, and cytogenetic features of ovarian cancers: implications for diagnosis and treatment. Radiographics. 31(3):625-46, 2011
                                                  7. American Joint Committee on Cancer: AJCC Cancer Staging Manual. 7th ed. New York: Springer. 419-28, 2010
                                                  8. Low RN et al: Diffusion-weighted MRI of peritoneal tumors: comparison with conventional MRI and surgical and histopathologic findings--a feasibility study. AJR Am J Roentgenol. 193(2):461-70, 2009
                                                  9. Suga K et al: F-18 FDG PET-CT findings in a case of normal-sized ovarian cancer syndrome. Clin Nucl Med. 34(10):706-9, 2009
                                                  10. Booth SJ et al: The accurate staging of ovarian cancer using 3T magnetic resonance imaging--a realistic option. BJOG. 115(7):894-901, 2008
                                                  11. Ferreira CR et al: Mucinous ovarian tumors associated with pseudomyxoma peritonei of adenomucinosis type: immunohistochemical evidence that they are secondary tumors. Int J Gynecol Cancer. 18(1):59-65, 2008
                                                  12. Fujii S et al: Detection of peritoneal dissemination in gynecological malignancy: evaluation by diffusion-weighted MR imaging. Eur Radiol. 18(1):18-23, 2008
                                                  13. Sebastian S et al: PET-CT vs. CT alone in ovarian cancer recurrence. Abdom Imaging. 33(1):112-8, 2008
                                                  14. Thomassin-Naggara I et al: Dynamic contrast-enhanced magnetic resonance imaging: a useful tool for characterizing ovarian epithelial tumors. J Magn Reson Imaging. 28(1):111-20, 2008
                                                  15. Tsili AC et al: Adnexal masses: accuracy of detection and differentiation with multidetector computed tomography. Gynecol Oncol. 110(1):22-31, 2008
                                                  16. Kim CK et al: Detection of recurrent ovarian cancer at MRI: comparison with integrated PET/CT. J Comput Assist Tomogr. 31(6):868-75, 2007
                                                  17. Liu J et al: Ultrasonography, computed tomography and magnetic resonance imaging for diagnosis of ovarian carcinoma. Eur J Radiol. 62(3):328-34, 2007
                                                  18. Chen M et al: Differentiation between malignant and benign ovarian tumors by magnetic resonance imaging. Chin Med Sci J. 21(4):270-5, 2006
                                                  19. Woodward PJ et al: From the archives of the AFIP: radiologic staging of ovarian carcinoma with pathologic correlation. Radiographics. 24(1):225-46, 2004
                                                  20. Seidman JD et al: Pathology of ovarian carcinoma. Hematol Oncol Clin North Am. 17(4):909-25, vii, 2003
                                                  21. Coakley FV: Staging ovarian cancer: role of imaging. Radiol Clin North Am. 40(3):609-36, 2002